This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Hiv-associated Lipodystrophy Syndrome
Information about Hiv-associated Lipodystrophy Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Hiv-associated Lipodystrophy Syndrome
Most recent studies have shown that Hiv-associated Lipodystrophy Syndrome shares some biological mechanisms with acquired-immunodeficiency-syndrome, atrophy, cardiovascular-diseases, diabetes-mellitus, dyslipidemias, hiv-infections, hiv-lipodystrophy, hyperlipidemia, immunologic-deficiency-syndromes, insulin-resistance, insulin-sensitivity, lipodystrophy, metabolic-diseases, metabolic-syndrome-x, mitochondrial-damage, obesity.
Among the many pathways, these few ones have gauged particular interests from scientists studying Hiv-associated Lipodystrophy Syndrome, and have been seen in publications frequently: Adiponectin Secretion, Aging, Cell Adhesion, Cell Cycle, Cell Proliferation, Cytokine Secretion, Drug Resistance, Excretion, Fatty Acid Transport, Glucose Homeostasis, Growth Hormone Secretion, Hormone Secretion, Hypersensitivity, Immune Response, Insulin Secretion, Lipid Oxidation, Pathogenesis, Secretion, Transport, Viral Replication
Quite a number of genes have been found to play important roles in Hiv-associated Lipodystrophy Syndrome, such as ADIPOQ, AGRP, ART2B, CD4, ERMAP, FMN1, FOXC2, GGH, GH1, GHRH, IGF1, IL18, IL6, INS, LEP, PPARG, SAT1, TG, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.